...
首页> 外文期刊>Journal of ocular pharmacology and therapeutics: The official journal of the Association for Ocular Pharmacology and Therapeutics >Tropicamide 1% mydriatic effect: Comparison between spray in closed eyes and eye drops in open eyes
【24h】

Tropicamide 1% mydriatic effect: Comparison between spray in closed eyes and eye drops in open eyes

机译:Tropicamide 1%散瞳效果:闭眼喷雾与睁眼眼药水的比较

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Purpose: The aim of this study was to evaluate by serial measurements, pupil mydriasis produced by topical application of tropicamide 1% using a spray in a closed eye or instillation in an open eye in adult and elderly populations. Methods: The research was done from February to April of 2011 in the Policlinica Ronaldo Gazolla, located in the Arcos da Lapa Campus of Estacio de Sá University, RJ- Brazil. It was a clinical trial, controlled and randomized, made in a series of 50 patients that were being prepared for ophthalmoscopy examination. They were submitted to eye drop administration of 1% tropicamide in an open eye and to eyelid margin vaporization in a closed eye. The eyes were chosen for the administration of drops or spray according to a pseudo-random numbers table from Excel (2007) before application. The pupil diameter was measured before instillation and after 10, 20, and 30min in both eyes, with a millimeter ruler. Biostat 5.0 software was used for statistical calculations. Results: Tropicamide 1% was vaporized in a group that presented the following average pupil diameters: 3mm before the application; 4.16mm in 10min; 5mm in 20min; and 5.35mm in 30min. The group in which tropicamide 1% was instilled presented 2.96mm of average pupil diameter before the application; 4.22mm at 10min; 5.02mm at 20min; and 5.44 at 30min. The two way analysis of variance showed P<0.0001, and the Tukey test performed for comparisons among the groups showed statistical significant differences among all groups except when the measurements were done at the same time. Conclusion: The vaporized tropicamide 1% mydriatic effect in closed eyes was clinically equivalent to the instillation effect of eye drop in open eyes. Other mydriatic drugs sprayed in closed eyes may not have the same effect.
机译:目的:本研究的目的是通过连续测量来评估成人和老年人人群中,在闭眼或喷雾眼中滴注1%托吡卡因局部应用所产生的瞳孔瞳孔散大。方法:该研究于2011年2月至2011年4月在巴西RJ Estacio deSá大学的Arcos da Lapa校园的Policlinica Ronaldo Gazolla中进行。这是一项针对50例准备进行检眼镜检查的患者进行的随机对照临床试验。他们在睁开的眼睛中接受1%托吡卡因的眼药水给药,在闭合的眼睛中进行眼睑边缘蒸发。在施用之前,根据来自Excel(2007)的伪随机数表选择用于滴眼或喷雾的眼睛。在滴注之前和10、20和30分钟后,用毫米尺测量瞳孔直径。使用Biostat 5.0软件进行统计计算。结果:在表现出以下平均瞳孔直径的一组中,将1%的托吡卡胺蒸发:施用前3毫米; 10分钟内达到4.16毫米; 20分钟内5毫米; 30分钟内达到5.35毫米。滴注1%的托吡卡胺的组在应用前的平均瞳孔直径为2.96mm。 10分钟时4.22毫米; 20分钟时为5.02毫米; 30分钟后为5.44。双向方差分析显示P <0.0001,并且在进行组间比较的Tukey检验中,除同时进行测量外,所有组之间的统计差异均有统计学意义。结论:闭眼中蒸发的托吡卡胺1%散瞳效果在临床上等同于睁眼滴眼液的滴注效果。闭眼喷洒的其他散瞳药物可能不会产生相同的效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号